LYRA- Lyra Therapeutics, Inc.

Name: Lyra Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Lyra Therapeutics, Inc. (LYRA) has 7 insiders with recent SEC Form 4 filings, including 8 buys and 16 sells. LYRA is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Palasis Maria	1.10M	$800.6K	-
CFO	Cavalier Jason	518.5K	$378.5K	-
Dir	Merrifield C Ann	32.0K	$23.4K	-
Dir	Tobin James R	32.0K	$23.4K	-
Dir	Snyderman Nancy Lynn Md	32.0K	$23.4K	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jan 6, 2026	Cavalier Jason	Chief Financial Officer	Sell	769	$3.36	$2,586.92	-0.1%	-85.4%	-
Jan 6, 2026	Palasis Maria65	President &CEO	Sell	1,702	$3.36	$5,725.53	-0.2%	-85.4%	-
Nov 13, 2025	Perceptive Advisors LLC51	10% Owner	Sell	45,875	$3.98	$182,515.31	-8.6%	-64.1%	-
Nov 10, 2025	Perceptive Advisors LLC51	10% Owner	Sell	70,390	$4.89	$344,219.10	-10.3%	-65.5%	-
Jul 10, 2025	Palasis Maria65	President &CEO	Sell	1,565	$8.91	$13,944.15	-0.1%	-14.8%	-
Jul 10, 2025	Cavalier Jason	Chief Financial Officer	Sell	684	$8.91	$6,094.44	-0.1%	-14.8%	-
Nov 10, 2023	Waksal Harlan	Executive Chair	Buy	25,000	$2.96	$74,095.00	+10.6%	+60.3%	-91.1%
May 31, 2023	Nbvm Gp, LLC	10% Owner	Buy	1,805,416	$2.43	$4,387,160.88	+44.2%	+32.7%	-87.1%
May 31, 2023	Perceptive Advisors LLC51	Director, 10% Owner	Buy	3,610,832	$2.49	$8,999,998.76	+45.9%	+32.7%	-87.1%
May 31, 2023	Anderson Edward T	Director, 10% Owner	Buy	1,805,416	$2.43	$4,387,160.88	+44.2%	+32.7%	-87.1%

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC